Anglia Ruskin University
JMDH-390364-evaluation-of-short-term-side-effects-following-the-first-do.pdf (684.65 kB)

Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India

Download (684.65 kB)
journal contribution
posted on 2023-07-26, 16:07 authored by Md Anwarul Azim Majumder, Keerti Singh, WMS Johnson, Archana Rajasundaram, Subir Gupta, Uma Gaur, Santosh Kumar, Madhuri Chatterjee, Ahbab Mohammad Fazle Rabbi, Vijay Prasad Sangishetti, Sayeeda Rahman, Michael H Campbell, Heather Harewood, Ambadasu Bharatha, Kandamaran Krishnamurthy, Russell Kabir, Ali Davod Parsa, Shegufta Mohammmad, Mainul Haque, Mohammed S Razzaque
Background: Efficacy and safety are fundamental for the development of successful COVID-19 vaccines. Vaccine-associated side effects influence vaccine hesitancy. This study investigated the prevalence, severity, and onset of side effects following the first dose of COVID-19 vaccines among physicians and dentists working in various healthcare settings across India. Methods: A cross-sectional survey collected self-report data from April to June 2021 on side effects following the first dose of the vaccine. An online validated questionnaire using the Google Docs® platform was circulated via email and social media platforms. Results: More than 40% of participants experienced at least one side effect after the first dose of vaccination; the most common were mild and resolved within three days after vaccination. More than 91% of respondents received the Covishield (AstraZeneca) vaccine; the most prevalent adverse effects were soreness of the injected arm (78.9%), tiredness (71.1%), and fever (54.9%). Logistic regression showed that women were almost 60% less likely to report side effects. Conclusion: Findings supported the safety of the first dose of the COVID-19 vaccine based on relatively few self-limiting side effects, mainly soreness of the injected arm and tiredness. Further research is needed to determine the long-term safety of COVID-19 vaccines, especially after booster doses.



  • Yes



Page range


Publication title

Journal of Multidisciplinary Healthcare




Informa UK Limited

File version

  • Published version


  • eng

Legacy posted date


Legacy creation date


Legacy Faculty/School/Department

COVID-19 Research Collection

Usage metrics

    ARU Outputs


    No categories selected